Publication | Closed Access

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial

Rheumatoid DisorderRheumatologyAnti-inflammatoryCardiovascular OutcomesGastrointestinal Event TrialPharmacologyClinical TrialsOsteoarthritisInflammatory Rheumatic DiseasePharmacotherapyTherapeutic Arthritis ResearchMedicineRheumatoid Arthritis